CN101284102B - Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof - Google Patents

Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof Download PDF

Info

Publication number
CN101284102B
CN101284102B CN2008100286060A CN200810028606A CN101284102B CN 101284102 B CN101284102 B CN 101284102B CN 2008100286060 A CN2008100286060 A CN 2008100286060A CN 200810028606 A CN200810028606 A CN 200810028606A CN 101284102 B CN101284102 B CN 101284102B
Authority
CN
China
Prior art keywords
hepatitis
preparation
medicine
chronic hepatitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008100286060A
Other languages
Chinese (zh)
Other versions
CN101284102A (en
Inventor
文怡海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Cheerful Biotechnology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008100286060A priority Critical patent/CN101284102B/en
Publication of CN101284102A publication Critical patent/CN101284102A/en
Application granted granted Critical
Publication of CN101284102B publication Critical patent/CN101284102B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a pharmaceutical for treating chronic hepatitis and hepatitis A and a preparation method thereof. The pharmaceutical is prepared from pop-gun seed 10-30 weight parts, coix seed 1-5 weight parts, malt 1-3 weight parts, and root of red rooted salvia 1-3 weight parts by directly pulverizing the materials, or spray drying into powder after water extraction. Clinical application shows that the preparation can be used for preventing and treating chronic hepatitis and hepatitis A with no toxic and side effect, good effect and high virus resistance, and the pharmaceutical has the advantages of convenient administration and carry-over, low cost and is widely accepted by patients.

Description

A kind of medicine for the treatment of chronic hepatitis and hepatitis A and preparation method thereof
Technical field
The present invention relates to prescription medicine for the treatment of chronic hepatitis, hepatitis A disease and preparation method thereof.
Background technology
Viral hepatitis is that the clinician treats a more thorny class infectious disease, because the hepatitis virus infectiousness is strong, spread scope is wide, be prone to severe complication, people health is caused great harm, and the medicine of existing treatment viral hepatitis exist the course of treatment long, the curative effect instability, easily form drug resistance, shortcoming such as costly is an important topic of current medical research and tackling key problem so treat various viral hepatitis.
Summary of the invention
The objective of the invention is to provide the chronic hepatitis that a kind of treatment causes by each Hepatitis virus and the prescription medicine of hepatitis A, acute icterohepatitis, acute anicteric hepatitis, drug-induced transaminase are raise etc. also significant curative effect; The characteristics of this prescription medicine are determined curative effects, and the suitability is wide, and toxic and side effects is little, and expense is cheap.
For achieving the above object, the medicine of treatment chronic hepatitis of the present invention and hepatitis A is mainly made by the crude drug of following weight: Bridelia monoica (Lour.) Merr. 10-30 part, Semen Coicis 1-5 part, Fructus Hordei Germinatus 1-3 part, Radix Salviae Miltiorrhizae 1-3 part.
Desirable its root of described Bridelia monoica (Lour.) Merr., stem or leaf are used as medicine, and as optimum selection, get its leaf and are used as medicine.
As optimization formula, the weight portion ratio of described each crude drug is: 10 parts on Bridelia monoica (Lour.) Merr. leaf, 3 parts of Semen Coiciss, 2 parts in Fructus Hordei Germinatus, 1.5 parts of Radix Salviae Miltiorrhizaes.
The medicine of treatment chronic hepatitis of the present invention and hepatitis A can adopt following preparation method to make: take by weighing various crude drug by described weight part ratio, pulverize separately becomes 100 orders, each the crude drug mix homogeneously after will pulverizing again, promptly.
The medicine of treatment chronic hepatitis of the present invention and hepatitis A also can adopt following preparation method to make: take by weighing various crude drug and each crude drug is mixed by described weight part ratio, add 8-12 and doubly measure 50-90 ℃ of hot water, soaked 1-2 hour, heating decocts, the back timing of boiling, and decocting time is 1.5-2.5 hour, filtration drying, get spray drying powder, be ground into 100 orders again, promptly.
The various conventional adjuvant that the medicated powder of any above-mentioned method gained needs when adding the different Chinese medicine preparation dosage form of preparation adopts conventional Chinese medicine preparation preparation method it can be prepared into common Chinese medicine preparation dosage form.
The major function of medicine of the present invention is: heat-clearing and toxic substances removing, dampness removing jaundice eliminating, blood circulation promoting and blood stasis dispelling, to treatment chronic hepatitis, hepatitis A, acute icterohepatitisshock, acute no icterohepatitis, medicine causes that the transaminase raises, unique curative effect is arranged, chronic hepatitis course of treatment of taking medicine is 30 days, drug-induced transaminase raises, and be 30-45 days the course of treatment of taking medicine, and examination of serum glutamate pyruvate transaminase, icteric index etc. are reduced to normally after taking medicine.
Through clinical treatment 4 routine disease analyses:
1, Deng, the man, 34 years old, whole body jaundice, weak, heating, yellow sclera, yellow urine were through certain city center hospital hospitalization one month, each symptom does not subtract, be diagnosed as the severe acute icterohepatitis,, took medicine 15 days through coming my out-patient treatment, the above-mentioned symptom complete obiteration, through result of laboratory test: liver function and every index are normal fully.
2, Zhang, woman, 35: malaise, inappetence, serum glutamic pyruvic transminase 550mmol/L was through certain the People's Hospital, city hospitalization three months, transference cure, healing is left hospital, one week of drug withdrawal, above-mentioned symptom appears again, and 4 times repeatedly, through treating one month with this medicine, full recovery is normal, chemical examination is normal, and result of laboratory test: liver function and every index are normal, not recurrence in 3 years.
3, Luo, man, 12 years old, be diagnosed as: fine ductility hepatitis, symptom: weak, inappetence, the transaminase raises and to be 146mmol/L, treat not have in 3 years to be clearly better, and takes this medicine treatment two months, recovers normally fully.
4, literary composition certain, the man 15 days, is diagnosed as: pathological jaundice of newborn, in the commentaries on classics of not getting better in 20 days of certain the People's Hospital, city hospitalization, through taking this medicine 5 days, the symptom complete obiteration, result of laboratory test: liver function and every function index are normal.
Chronic hepatitis, hepatitis A are the higher infectious diseases of a kind of sickness rate, bring very big misery to extensive patients.Medicine of the present invention is applicant's a secret prescription handed down in the family from generation to generation, and through two clinically uses during the last ten years, treatment chronic hepatitis, hepatitis A have no side effect, good drug efficacy, antiviral is strong, through treatment chronic hepatitis, clinical 830 examples of hepatitis A, treatment 98% is always arranged, cure 90-95%.This drug administration is subjected to patient's approval deeply with easy to carry, economical and practical, is prevention and the good Chinese medicine for the treatment of chronic hepatitis, hepatitis A, is worth using.
The specific embodiment
Embodiment 1:
Take by weighing Bridelia monoica (Lour.) Merr. leaf 1kg, Semen Coicis 300g, Fructus Hordei Germinatus 200g, Radix Salviae Miltiorrhizae 150g, pulverize separately becomes 100 orders, and each the crude drug mix homogeneously after will pulverizing again contains 0.3 gram packing by every capsules and gets final product.The patient is oral, and every day 3 times, each 4 capsules are taken 2-4 the course of treatment 7 days course of treatment, and the state of an illness can take an evident turn for the better.
Embodiment 2:
Take by weighing Bridelia monoica (Lour.) Merr. leaf 1kg, Semen Coicis 300g, Fructus Hordei Germinatus 200g, Radix Salviae Miltiorrhizae 150g; Add 8-12 times of dose 50-90 ℃ hot water, soaked 1-2 hour, heating decocts, the back timing of boiling, and decocting time is 2-3 hour, filters; Medicinal residues add 5-7 times of water gaging again, and heating decocts, and decocting time is 1.5-2.5 hour, filter, and filtrate merges, and puts the centrifuge separating solid substances; Being concentrated into relative density is 1.1-1.2, and spray drying gets spray drying powder, is ground into 100 orders again.The various conventional adjuvant that needs when adding the different Chinese medicine preparation dosage form of preparation adopts conventional Chinese medicine preparation preparation method it can be prepared into common Chinese medicine preparation dosage form, as capsule, tablet, powder etc.
Embodiment 3:
Take by weighing Bridelia monoica (Lour.) Merr. stem 2kg, Semen Coicis 300g, Fructus Hordei Germinatus 200g, Radix Salviae Miltiorrhizae 150g, pulverize separately becomes 100 orders, and each the crude drug mix homogeneously after will pulverizing again contains 0.3 gram packing by every capsules and gets final product.The patient is oral, and every day 3 times, each 4 capsules are taken 2-4 the course of treatment 7 days course of treatment, and the state of an illness can take an evident turn for the better.
The above-mentioned specific embodiment is a preferred embodiment of the present utility model; can not limit claim of the present invention; other any change or other equivalent method of replacing that does not deviate from the novel technical scheme of this use and made is included within the protection domain of the present utility model.

Claims (4)

1. a medicine for the treatment of chronic hepatitis and hepatitis A is made by following bulk drugs: 10 parts on Bridelia monoica (Lour.) Merr. leaf, 3 parts of Semen Coiciss, 2 parts in Fructus Hordei Germinatus, 1.5 parts of Radix Salviae Miltiorrhizaes.
2. the preparation method of the medicine of treatment chronic hepatitis according to claim 1 and hepatitis A is characterized in that: take by weighing various crude drug by described weight part ratio, pulverize separately becomes 100 orders, each the raw material mix homogeneously after will pulverizing again, promptly.
3. the preparation method of the medicine of treatment chronic hepatitis according to claim 1 and hepatitis A, it is characterized in that: take by weighing various crude drug and each crude drug is mixed by described weight part ratio, add 8-12 and doubly measure 50-90 ℃ of hot water, soaked 1-2 hour, heating decocts, timing after boiling, decocting time is 1.5-2.5 hour, and filtration drying gets spray drying powder, be ground into 100 orders again, promptly.
4. according to claim 2 or 3 described preparation methoies, it is characterized in that: the various conventional adjuvant of needs when gained medicated powder adds the different Chinese medicine preparation dosage form of preparation, adopt the Chinese medicine preparation preparation method of routine that it is prepared into common Chinese medicine preparation dosage form.
CN2008100286060A 2008-06-06 2008-06-06 Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof Expired - Fee Related CN101284102B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008100286060A CN101284102B (en) 2008-06-06 2008-06-06 Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008100286060A CN101284102B (en) 2008-06-06 2008-06-06 Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof

Publications (2)

Publication Number Publication Date
CN101284102A CN101284102A (en) 2008-10-15
CN101284102B true CN101284102B (en) 2010-09-29

Family

ID=40056657

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008100286060A Expired - Fee Related CN101284102B (en) 2008-06-06 2008-06-06 Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101284102B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115157C (en) * 2000-08-24 2003-07-23 张汉三 Method for preparing liver recovery decoction for curing liver disease
CN1195541C (en) * 2003-02-09 2005-04-06 王辅民 Medicine combination for treating chronic hepatitis B

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115157C (en) * 2000-08-24 2003-07-23 张汉三 Method for preparing liver recovery decoction for curing liver disease
CN1195541C (en) * 2003-02-09 2005-04-06 王辅民 Medicine combination for treating chronic hepatitis B

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
宓余强.慢性乙型肝炎证型与方药的筛选研究.中华中医药杂志(原中国医药学报)增刊.2007,316-317. *
杨鹏,等.加味茵陈蒿汤治疗急性病毒性肝炎68例.甘肃中医.2007,20(12),31-32.
杨鹏等.加味茵陈蒿汤治疗急性病毒性肝炎68例.甘肃中医.2007,20(12),31-32. *
王俊槐.谈诊治肝炎病湿热证的经验.中国中西医结合杂志.1995,15(10),635. *

Also Published As

Publication number Publication date
CN101284102A (en) 2008-10-15

Similar Documents

Publication Publication Date Title
CN102940779A (en) Medicine composition for treating chronic ulcerative colitis and preparation process of medicine composition
CN104667044A (en) Traditional Chinese medicine preparation for treating arthralgia and preparation method of traditional Chinese medicine preparation
CN101670051B (en) Traditional Chinese medicine for treating toothache
CN101347605B (en) Chinese medicinal composition for treating gout and preparation method and application thereof
CN102657736B (en) Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition
CN101972465A (en) Medicinal preparation for treating primary dysmenorrhea and preparation method thereof
CN101284102B (en) Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof
CN109289009A (en) A kind of Chinese medicine composition and its preparation method and application
CN103705812B (en) A kind of pharmaceutical composition for the treatment of gout and its production and use
CN102908443A (en) Medicinal composition for therapy or adjuvant therapy of aids, preparation method of medicinal composition and application of medicinal composition
CN106237263A (en) A kind of treat acute icterohepatitis and Chinese medicine composition that chronic hepatitis acute onset raises with bilirubin
CN101912442A (en) Micro-enema for treating upper respiratory track infection and preparation method thereof
CN110613822A (en) Anti-hepatitis B virus traditional Chinese medicine formula
CN102488851B (en) Drug for treating recurrent genital herpes and preparation method thereof
CN101829188B (en) Medicament for treating urinary infection and lithiasis
CN102813873A (en) Traditional Chinese medicine composition for treating mental diseases, and preparation method, application and quality control thereof
CN100464767C (en) Medicine composition for treating hyperuricemia
CN1261130C (en) Medicine for dispelling tinea
CN1824075B (en) Medicinal composition for treating hemicrania and its application
CN103599265A (en) Compound traditional Chinese medicine for radiation protection
CN103142928A (en) Iliacus muscle oral liquid and preparation method thereof
CN102940740A (en) Medicament for treating lithiasis and preparation method thereof
CN102805795B (en) Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof
CN105497127A (en) Nerve protection use of Chinese medicinal composition
CN1872165A (en) A medicine combination, preparation method and method for controlling quality

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SHENZHEN YUYUE BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: WEN YIHAI

Effective date: 20140624

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20140624

Address after: 518000, Guangdong, Longhua New District, Longhua street, Shenzhen garden, 80 Garden Village, 3 floor

Patentee after: Shenzhen cheerful Biotechnology Co., Ltd.

Address before: Guangdong city of Shenzhen province Baoan District 518000 Meiyuan Longhua Minzhi plum hill No. 34 wing

Patentee before: Wen Yihai

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100929

Termination date: 20210606

CF01 Termination of patent right due to non-payment of annual fee